Tech, Pharma Gains Push South Korean Shares; Hanmi Semiconductor Jumps 14% on Seventh Factory Construction

MT Newswires Live01-08 16:33

South Korean shares closed higher on Wednesday, extending gains for a third day, owing to gains made by technology and pharmaceutical shares.

The Korea Composite Stock Price Index, or Kospi, was up by 28.95 points, or 1.2%, to close at 2,521.05. The Kosdaq also rose by 1.34 points, or 0.2%, to end at 719.63.

In economic news, South Korea's current account surplus decreased to $9.30 billion in November 2024 from $9.78 billion in previous month, according to preliminary data from the Bank of Korea released Wednesday.

Compared with the year-ago period, the figure increased from a surplus of $3.89 billion, the central bank said.

The goods account registered a surplus of $9.75 billion, driven by a 1.2% annual increase in exports to $57.10 billion and a 4.4% decrease in imports to $47.35 billion from the previous year.

Meanwhile, the services account posted a deficit of $2.09 billion, primarily due to deficits in manufacturing services, travel, and other business services accounts.

The primary income account recorded a $1.94 billion surplus in the month, owing to higher interest income, the central bank said.

In corporate news, Hanmi Semiconductor (KRX:042700) began the construction of its seventh factory to produce thermocompression (TC) bonding bonders, essential for high-bandwidth memory manufacturing, the company said Tuesday.

The two-story, 4,356 pyeong facility, near the company's existing six production sites in Seo-gu, Incheon, is slated for completion by the fourth quarter of 2025. The expanded capacity is expected to boost sales potential to around 2 trillion won, the release said.

Shares of Hanmi Semiconductor jumped more than 14% at market close on Wednesday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment